<SEC-DOCUMENT>0001279569-24-001129.txt : 20240917
<SEC-HEADER>0001279569-24-001129.hdr.sgml : 20240917
<ACCEPTANCE-DATETIME>20240917071940
ACCESSION NUMBER:		0001279569-24-001129
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20240917
FILED AS OF DATE:		20240917
DATE AS OF CHANGE:		20240917

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AURORA CANNABIS INC
		CENTRAL INDEX KEY:			0001683541
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38691
		FILM NUMBER:		241302586

	BUSINESS ADDRESS:	
		STREET 1:		2207 90B STREET SW
		CITY:			EDMONTON
		STATE:			A0
		ZIP:			T6X 1V8
		BUSINESS PHONE:		604-362-5207

	MAIL ADDRESS:	
		STREET 1:		409 GRANVILLE STREET
		STREET 2:		SUITE 1700
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6C 1T2
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>aurora_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B></FONT></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>FORM 6-K</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>REPORT OF
FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<BR>
 UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">For the month
of <B> September 2024</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Commission File
No. <B>001-38691</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 16pt"><B><U>AURORA
CANNABIS INC.</U></B></FONT><B><FONT STYLE="font-size: 10pt"><BR>
</FONT></B><FONT STYLE="font-size: 10pt">(Translation of registrant's name into English)</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>2207 90B St. SW <BR>
Edmonton, Alberta T6X 1V8 <BR>
Canada</B><U><BR>
</U>(Address of principal executive office)</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0"><FONT STYLE="font-size: 10pt">Indicate by check mark whether the
registrant files or will file annual reports under cover of Form 20-F or Form 40-F</FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 10pt">Form 20-F&nbsp;&nbsp;&#9744;
<B>Form 40-F&nbsp;&nbsp;&#9746;</B></FONT></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>SUBMITTED HEREWITH</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; font: 12pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibits</B></FONT></TD>
    <TD STYLE="width: 2%"></TD>
    <TD STYLE="width: 90%; font: 12pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Description&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><A HREF="ex991.htm">99.1</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-transform: none"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-transform: none"><A HREF="ex991.htm">News
    Release dated September 17, 2024</A></FONT></TD></TR>

</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>AURORA CANNABIS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">/s/ <I>Miguel Martin</I></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><I></I><BR>
Miguel Martin<BR>
Chief  Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Date: September 17, 2024</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>NEWS RELEASE DATED SEPTEMBER 17, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT>&nbsp;</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 9pt Tahoma, Helvetica, Sans-Serif; margin: 0 0 0 346.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 9pt Tahoma, Helvetica, Sans-Serif; margin: 0 0 0 346.05pt"></P>

<P STYLE="font: 11pt/87% Tahoma, Helvetica, Sans-Serif; text-align: left; margin: 2.95pt 0 0 6pt"><IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="font: 11pt/87% Tahoma, Helvetica, Sans-Serif; margin: 2.95pt 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 11pt/87% Tahoma, Helvetica, Sans-Serif; margin: 2.95pt 0 0 6pt; text-align: left">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora Cannabis Advances Auto-Flowering Research,
Unveiling Key Insights for Future Cultivation Excellence</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; text-align: center; margin-right: 0; margin-left: 0"><I>Auto-Flowering Breakthroughs
Poised to Transform Cannabis Cultivation in High-Latitude Regions, Opening New Doors for Advanced Breeding Strategies</I></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">EDMONTON, AB, Sept. 17, 2024 /PRNewswire/ -- <B>Aurora
Cannabis Inc. </B>(NASDAQ: ACB) (TSX: ACB) &ndash;the Canadian based leading global medical cannabis company, is pioneering ground-breaking
research in auto-flowering technology. Auto-flowering is a genetic characteristic that automatically transitions the plant from the vegetative
stage to the flowering stage rather than relying on changes in light cycles. This innovative work provides foundational insight on flowering
mechanism in cannabis, which will support future breeding strategies, and can be leveraged to revolutionize outdoor cannabis cultivation
in high-latitude regions, such as Canada.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;As a company backed by science, we have long
invested in research both independently and with leading academic institutions, and have achieved significant learning from our work,&quot;
says Jose Celedon, PhD, Director, Breeding and Genetics at Aurora. &quot;Our recent work on auto-flowering will be a gamechanger for cannabis
and hemp production. This research speaks to our expertise and investment in science that will move this industry forward.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Most of the commercially grown cannabis is photoperiod
sensitive, meaning that plants require shifts in day length to trigger flowering. While this can be controlled readily in indoor production,
it is a limitation for outdoor cultivation, especially in high-latitude regions. Aurora has received a US Patent 12,002,546, &quot;Methods
of Determining Sensitivity to Photoperiod in Cannabis&quot;, which enables Aurora's breeding program to identify and select for the auto
flowering trait. This latest research solidifies Aurora's position as an innovative industry leader, poised to shape the future of cannabis
agriculture.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora's commitment to research and innovation has
generated tangible results for the Company, significantly improving potency and yield, thereby driving down cost per gram and increasing
overall efficiency. Aurora has significantly invested in cannabis breeding since 2018, and the novel cultivars identified from this world
class breeding program consistently yield 40-100% more flower than legacy varieties.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The company's focus on unravelling the molecular mechanisms
controlling flowering and maturity time in cannabis holds promise for enhancing crop yield and adaptability. By exploiting the natural
variation in the circadian rhythm of cannabis, Aurora aims to elevate the economic value of both medical and recreational cannabis. Through
leveraging genetic research and development, the company aims to overcome traditional limitations, paving the way for improved cultivation
techniques and market opportunities.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Aurora Cannabis<BR>
</B>Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South
America. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives.
The Company's adult- use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis
brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed
and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural
plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through
as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at <B>www.auroramj.com</B>
and follow us on X and LinkedIn.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora's Common Shares trade on the NASDAQ and TSX
under the symbol &quot;ACB&quot;.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Forward Looking Information </B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">This news release includes statements containing certain
&quot;forward-looking information&quot; within the meaning of applicable securities law (&quot;<B>forward-looking statements</B>&quot;).
Forward-looking statements are frequently characterized by words such as &quot;plan&quot;, &quot;continue&quot;, &quot;expect&quot;, &quot;project&quot;,
&quot;intend&quot;, &quot;believe&quot;, &quot;anticipate&quot;, &quot;estimate&quot;, &quot;may&quot;, &quot;will&quot;, &quot;potential&quot;,
&quot;proposed&quot; and other similar words, or statements that certain events or conditions &quot;may&quot; or &quot;will&quot; occur.
Forward-looking statements made in this news release include, but are not limited to, statements regarding the Company's research in auto-flowering
technology and associated benefits, including supporting future cannabis breeding strategies, improvements in potency, yield, cost per
gram and efficiency and the impact on outdoor cannabis cultivation in high-altitude regions and on the future of cannabis agriculture,
as well as statements regarding the Company's plans for continued genetic research and development to elevate the economic value of medical
and recreational cannabis.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">These forward-looking statements are only predictions.
Forward looking information or statements contained in this news release have been developed based on assumptions management considers
to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from market research and industry analysis and on assumptions based on data
and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks,
uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events,
results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking
statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure
to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and
retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand
in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration
of acquired business and operations (with respect to the Transaction and more generally with respect to future acquisitions), management's
estimation that SG&amp;A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities,
the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand,
changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry,
epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading &quot;Risk Factors&quot;
in the Company's annual information from dated June 20, 2024 (the &quot;AIF&quot;) and filed with Canadian securities regulators available
on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov. The Company
cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely
affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking
statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims
any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable securities law.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:https://www.prnewswire.com/news-releases/aurora-cannabis-advances-auto-flowering-research-unveiling-key-insights-for-future-cultivation-excellence-302250032.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SOURCE Aurora Cannabis Inc.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2024/17/c6172.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">%CIK: 0001683541</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For further information: </B>For Media: Michelle Lefler, VP, Communications
&amp; PR, media@auroramj.com, OR For Investors: ICR, Inc., aurora@icrinc.com</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CO: Aurora Cannabis Inc.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CNW 07:00e 17-SEP-24</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  U 0,# 2(  A$! Q$!_\0
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M8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?!OCF>#]HJW\7^']=MX[:^M/$EC\-O MGK,T:17-TKZ?>W\$][ILQF,DUC/
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MSXN?L!P> /B+XZ\#0ZG\.?CY+J4/@_Q=X@\,Q:A+;>)OABEO+?1Z+J%DEW)
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M=8TN1]=M;77])%Y;2VDT]I+?Z?\ :8+BPNOWL<]NO^G!_P &YO\ P5*\8_\
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M0/\ A/=6N_C!\'_#/C?]F+XEZ_J%[>WOB+0O$WAZ*^C\!Z_+?SW\NJ:A+/\
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M\)8BO4I*AAL5&OFKS7,,51S.AA\!B<"J558F?]+OPW^&WP:\(6P\1_"3P/\
M#CPY9^*=,L+E=>^'_A_PYIMKXAT:9!?:7<1ZIH%K%%JNF31W"WEC,D\]K*DR
MW$#,KJY]0KXV_8I^'WB;PS\*=$\;^*?&7QGU*\^)7A7P=K-I\.OBSKD%[#\*
M])MM.NI-'\/:-X<;X:_#34_!FL/I6HV-MXS\/:EI5P;#6=+CL;618K(RW/V3
M7X-F=3$5<?BGBL;B,QK0JSHO&8K$8C%5JT:$ITH<U;$XC%U9<L(**7UBI3A:
M4:3]FHN7]F\/T,%A\FR]9?E&!R+"UL-2Q<<KR[!8++L)AJF+ITL365/"9?@<
MMPT'4J574E+ZE0K5.:$\1'V[J*'E/QW^*VA_ CX(?&'XW>)I8X?#WP?^%WC[
MXG:V\LB1I_9?@3PMJOB>^4O+)$@:2WTN2- TB;G95# D5_A.?%'XG^./C1\3
M_'WQA^)&N7?BGXA_$[QIXB\?^-/$&H$3W6M>*?%>L76N:U?SJX9#]JU&]G=8
M ODQQLL$:")%0?[1/_!73]C?XZ?M_?L-_$S]DKX"_%_PG\$=<^+NI>&-)\;>
M,O%^BZMKEC<_#73]476?$WABSM]&(O+>\\27.GZ1IUQ<_P"J.BOJ]HQ1[M'3
M\!_^".'_  :R^)_^"=G[:>@?M6_M _'3X2?'O2_ ?@7QIIW@'P9X;\$>);&3
M3OB!XKM;3P];^*M0D\2SR:=-:Z3X3OO%MI;VYM;B9=4U/3[Z'R9+%95X3V#^
M&W]I'_@LA_P4O_:Z^!MU^S7^T3^TQK'Q'^!UU+X7GD^'US\,_@WX<TR&3P5=
MVE]X7:QOO!_PY\/:UIBZ//96PMX].U.UC>V1[*X6:SFF@D^F_P#@VX_:RT/]
MD+_@KM^S3XI\8ZW_ &!X ^+DWB3]G?QMJ$ES:V=C%:_%O3!I7@^75[J\DBM[
M;1K'XHV?@'5-4N9)8Q;6EA+<Y/E;6_UXM6^%GPVUS2M3T75/ ?A"ZTS6-/O=
M*U&U;P[I*K<V&H6TMI>6[,EHKA9K>:2-BK!@&)!!P:_SY/$7_!DE^T5'XNUS
M4/ W[;WP7TSPW'XCU*]\'QZKX!^( U[3]$74II] 349[.]E@_M:TL1:+=S6L
MTD1O(Y)(9&4J: /N?_@]T\+:]??LF_L5>,;33;JX\.>&_P!H/QSH6MZI%!+)
M:Z=J?BOX=K>:#;74R(T4#:C#X5UPV_FNAE:R=(PY!V_@-_P:S_\ !3K]E/\
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MWB#Q1-K\WCG5O"6I6US8RZ+J=@EI'8)X<FBGCN%D:5KF-HV 1A6K_P $!?\
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M-M'U?_A,?#%W+>^ /'&AWNJSMI\&H:*FH>(M"U&&=3#?Z)XCNRZ/>Z?I<EN
M?QX?\'9&C:II?_!:_P"/]]J%C<6EIXC^&O[/6LZ'//%)'%J>EP?!WPIX>FOK
M-W55GMX]:T'6--:6(O&+O3[J L)89$7]_P#_ (-R_P#@O%_P33_91_X)J_#?
M]E#]J/XY7/P+^*GP;\3_ !:O+I/$_@/Q]KGA_P 7Z+XZ^)?B7XA:3JGA?6_
MWAOQ5:O+!;^*CH][I6K#2M3CO]+N9H;6>QGM;J;]\_\ @LI_P0R_9T_X*_\
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M2?VC_LB?!+4?V:_V4OV:_P!G76==L?%6J_ KX#?";X/ZIXETVRGT_3?$-_\
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M9;7#X@CNY3J46JQZDD=VO]?_ /P3\_X-"/B]^RC^VG^S=^TI\6OVI/@M\3_
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!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
